Synthesis of Fused Pyrimidinone and Quinolone Derivatives in an Automated High-Temperature and High-Pressure Flow Reactor.

J Org Chem

Discovery Chemistry and Technologies, AbbVie, Inc. , 1 North Waukegan Road, North Chicago, Illinois 60064, United States.

Published: January 2017

Fused pyrimidinone and quinolone derivatives that are of potential interest to pharmaceutical research were synthesized within minutes in up to 96% yield in an automated Phoenix high-temperature and high-pressure continuous flow reactor. Heterocyclic scaffolds that are either hard to synthesize or require multisteps are readily accessible using a common set of reaction conditions. The use of low-boiling solvents along with the high conversions of these reactions allowed for facile workup and isolation. The methods reported herein are highly amenable for fast and efficient heterocycle synthesis as well as compound scale-ups.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.joc.6b02520DOI Listing

Publication Analysis

Top Keywords

fused pyrimidinone
8
pyrimidinone quinolone
8
quinolone derivatives
8
high-temperature high-pressure
8
flow reactor
8
synthesis fused
4
derivatives automated
4
automated high-temperature
4
high-pressure flow
4
reactor fused
4

Similar Publications

Engineering CjCas9 for Efficient Base Editing and Prime Editing.

CRISPR J

December 2024

Gene Editing Center, School of Life Science and Technology, ShanghaiTech University, Shanghai, China.

Article Synopsis
  • The CRISPR-Cas9 system is utilized for gene therapy but faces challenges with packaging the Cas9 protein in viral vectors, limiting its clinical use.
  • Researchers developed enhanced versions of base editors (enCjBEs and enCjABEs) using a smaller Cas9 protein (CjCas9) which showed improved editing efficiencies for converting specific DNA bases.
  • New variants like SsenCjPE significantly increase prime editing efficiency and can be further improved by combining with other proteins, making them promising tools for both research and medical applications.
View Article and Find Full Text PDF

The Persistence of Hydrogen Bonds in Pyrimidinones: From Solution to Crystal.

ACS Org Inorg Au

October 2024

Núcleo de Química de Heterociclos (NUQUIMHE), Department of Chemistry, Federal University of Santa Maria (UFSM), 97105-900 Santa Maria, Rio Grande do Sul, Brazil.

Pyrimidinone scaffolds are present in a wide array of molecules with synthetic and pharmacological utility. The inherent properties of these compounds may be attributed to intermolecular interactions analogous to the interactions that molecules tend to establish with active sites. Pyrimidinones and their fused derivatives have garnered significant interest due to their structural features, which resemble nitrogenous bases, the foundational building blocks of DNA and RNA.

View Article and Find Full Text PDF

RNA modifications play an important role in actively controlling recently created formation in cellular regulation mechanisms, which link them to gene expression and protein. The RNA modifications have numerous alterations, presenting broad glimpses of RNA's operations and character. The modification process by the TET enzyme oxidation is the crucial change associated with cytosine hydroxymethylation.

View Article and Find Full Text PDF

The potential of mesenchymal stem cell coexpressing cytosine deaminase and secretory IL18-FC chimeric cytokine in suppressing glioblastoma recurrence.

Int Immunopharmacol

December 2024

Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address:

Glioblastoma multiforme (GBM) patients have a high recurrence rate of 90%, and the 5-year survival rate is only about 5%. Cytosine deaminase (CDA)/5-fluorocytosine (5-FC) gene therapy is a promising glioma treatment as 5-FC can cross the blood-brain barrier (BBB), while 5-fluorouracil (5-FU) cannot. Furthermore, 5-FU can assist reversing the immunological status of cold solid tumors.

View Article and Find Full Text PDF

Programmable DNA pyrimidine base editing via engineered uracil-DNA glycosylase.

Nat Commun

July 2024

Biomedical Pioneering Innovation Center, Peking-Tsinghua Center for Life Sciences, Peking University Genome Editing Research Center, State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, People's Republic of China.

DNA base editing technologies predominantly utilize engineered deaminases, limiting their ability to edit thymine and guanine directly. In this study, we successfully achieve base editing of both cytidine and thymine by leveraging the translesion DNA synthesis pathway through the engineering of uracil-DNA glycosylase (UNG). Employing structure-based rational design, exploration of homologous proteins, and mutation screening, we identify a Deinococcus radiodurans UNG mutant capable of effectively editing thymine.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!